2. All fixed-dose combinations approved for sale in India are considered rational and therapeutically superior to single-drug formulations. 3. FDCs do not require separate regulatory approval if each individual drug component has already been approved. How many of the statements given above are correct? (a) Only one (b) Only two (c) All three (d) None Why this question for UPSC Prelims 2027? The question is relevant because fixed-dose combinations (FDCs) have been in the news due to concerns over irrational drug combinations, regulatory oversight, and recent actions by drug authorities to review and prohibit unsafe formulations. The topic integrates science…
News Timeline:
Track the development of this news story across the Internet.